PULSE › Topics › Pelacarsen
Pelacarsen
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Novartis experiences a trial failure with pelacarsen, impacting the Dow and raising questions for competitors like Amgen and Lilly.
1 sources
1 articles
v 1
47d ago
◼ Archived
Business
🔮 fades ✗
A failed Novartis clinical trial for a cholesterol drug has triggered a biopharma selloff and cast doubt on competing efforts by Amgen and Eli Lilly.
3 sources
4 articles
v 2
46d ago
◼ Archived
Business
🔮 fades ✗
Novartis shares decline after its cholesterol drug pelacarsen failed a critical late-stage cardiovascular trial, impacting expectations for heart disease treatments.
4 sources
5 articles
v 3
47d ago
\n
\n
\n